Printer Friendly
The Free Library
14,799,752 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

E-Z-EM, Inc. Announces Financial Results and Conference Call Dates for Third Quarter Fiscal 2006.


LAKE SUCCESS, N.Y. -- E-Z-EM, Inc. (Nasdaq: EZEM) today announced that the company will release financial results for the third quarter of fiscal 2006 ended March 4, 2006 after market close on Tuesday, April 11, 2006.

Anthony A. Lombardo, president and chief executive officer, and Dennis J. Curtin, chief financial officer, will host an investment conference call beginning at 4:30 p.m. Eastern Time on Tuesday, April 11, 2006 to discuss these results and to answer questions.

To participate, please dial (877) 815-7177 from the U.S. or (706) 679-0753 from outside the U.S. In addition, a telephone replay of the call will be accessible for a limited time following completion of the call by dialing (800) 642-1687 or (706) 645-9291 and entering reservation number 7522252.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of E-Z-EM's web site at www.ezem.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software. A replay will be available on the Web site for a limited time.

About E-Z-EM, Inc.

E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal radiology. The Company recently introduced VoLumen(R) the next generation low density barium sulfate suspension Barium sulfate suspension is barium sulfate (powder) turned into a liquid form by suspending it in a quick-flowing drink to aid in CT scans of the gastrointestinal region. Use  for use as an oral contrast in Multidetector CT (MDCT MDCT Modified Discrete Cosine Transform
MDCT Multi-detector Computed Tomography
MDCT Multiple Description Correlating Transform
MDCT Motorsport Dual Clutch Transmission
) and PET/CT PET/CT Positron Emission Tomography and Computed Tomography  studies. The Company also offers Empower(R) -- the only family of CT injectors on the market with patented EDA(TM) technology that can help detect contrast extravasation extravasation /ex·trav·a·sa·tion/ (ek-strav?ah-za´shun)
1. a discharge or escape, as of blood, from a vessel into the tissues; blood or other substance so discharged.

2. the process of being extravasated.
 -- and offers a complete product set for the virtual colonoscopy practitioner. This product line consists of virtual colonoscopy hardware, software, nutritional prep kits and bowel cleaners, tagging agents and a carbon dioxide colon insufflation insufflation /in·suf·fla·tion/ (-sah-fla´shun)
1. the act of blowing a powder, vapor, or gas into a body cavity.

2. finely powdered or liquid drugs carried into the respiratory passages by such devices as aerosols.
 system. The Company is also the exclusive global manufacturer and marketer of Reactive Skin Decontamination decontamination /de·con·tam·i·na·tion/ (de?kon-tam-i-na´shun) the freeing of a person or object of some contaminating substance, e.g., war gas, radioactive material, etc.

de·con·tam·i·na·tion
n.
 Lotion (RSDL) for first-responder organizations and military services in many countries. RSDL is a liquid skin decontaminant that breaks down chemical agents such as Sarin sarin (zärēn`), volatile liquid used as a nerve gas. It boils at 147°C; but evaporates quickly at room temperature; its vapor is colorless and odorless.  or VX in seconds, leaving a non-toxic liquid that can be washed away with water.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 4, 2006
Words:354
Previous Article:First Marblehead Announces New Direct-to-Consumer Contract with Bank of America.
Next Article:AERT Announces First Quarter Gross Sales.
Topics:



Related Articles
E-Z-EM, Inc. Announces Financial Results and Conference Call Dates for First Quarter Fiscal 2006.
E-Z-EM Reports Record Financial Results from Continuing Operations for First Quarter of Fiscal 2006; Increases Financial Guidance; Conference Call to...
E-Z-EM, Inc. Announces Financial Results and Conference Call Dates for Second Quarter Fiscal 2006.
E-Z-EM Reports Second Quarter Fiscal 2006 Financial Results; Increases Financial Guidance; Conference Call to Begin at 4:30 p.m. Eastern Time...
E-Z-EM Reports Third Quarter Fiscal 2006 Financial Results; Conference Call to Begin at 4:30 p.m. Eastern Time Tuesday, April 11, 2006.
E-Z-EM Reports First Quarter Financial Results.
E-Z-EM, Inc. to Hold Fiscal 2007 First Quarter Financial Results Conference Call on Tuesday, October 10, 2006.
E-Z-EM Reports Second Quarter Fiscal 2007 Financial Results.
E-Z-EM, Inc. to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, April 10, 2007.
E-Z-EM Reports Third Quarter Fiscal 2007 Financial Results.(Financial report)

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles